
Loading, please wait...

Loading, please wait...

Researchers have recently developed a novel cascade nanozyme inflammation therapy to address the persistent challenges of reactive oxygen species (ROS) in inflammatory diseases. Chronic inflammation typically leads to high ROS levels. These molecules cause irreversible damage by destroying nucleic acids, proteins, and lipids. Consequently, effectively eliminating excess ROS remains a crucial step in modern medicine. This study introduces a sophisticated platform using ferrihydrite (Fh) and oxidative carbon dots (C-dots) to mimic natural enzyme properties.
The research team synthesized Fh using an innovative copper oxide (CuO)-promoted ferric iron hydrolysis method. This specific approach successfully addressed product sensitivity issues seen in previous manufacturing techniques. Furthermore, the scientists combined these Fh particles with oxidative carbon dot nanozymes through electrostatic and coordination interactions. This process resulted in a stable cascade nanozyme, designated as Fh@C-dot. Additionally, characterization results confirmed that the binding process was highly efficient. Therefore, the composite material retains the unique strengths of both individual components.
During the evaluation, the Fh@C-dot composite demonstrated remarkable catalytic performance. Specifically, Fh exhibited strong catalase (CAT)-like activity. Meanwhile, the C-dots showed excellent superoxide dismutase (SOD)-like activity and hydroxyl radical scavenging capabilities. Moreover, the integrated Fh@C-dot platform possessed both radical scavenging properties and enhanced CAT-like activity. In addition to its chemical efficacy, the platform showed exceptional biosafety. Specifically, in vivo tests on mice confirmed significant therapeutic effects on irritant contact dermatitis. Consequently, this innovation provides a potential alternative to traditional natural antioxidants for treating localized skin inflammation.
The Fh@C-dot nanozyme offers a dual-action approach. It provides both CAT-like and SOD-like activities to scavenge multiple types of reactive oxygen species effectively. Its enhanced radical scavenging ability makes it more potent than individual nanozymes.
The platform targets the oxidative stress at the site of inflammation. By eliminating excess ROS, it prevents cellular damage and reduces the inflammatory response in the skin tissue, as demonstrated in mice models.
Yes, the novel CuO-promoted ferric iron hydrolysis method reduces sensitivity to reaction parameters. This ensures a more consistent and higher quality production of ferrihydrite for medical applications.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional diagnosis. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers developed Fh@C-dot, a cascade nanozyme platform that scavenges reactive oxygen species to treat inflammation and irritant contact dermatitis....
4 months ago

A new case study illuminates how functional connectivity changes drive recovery from pure alexia following posterior cerebral artery infarction. Functional reorganization supports reading recovery despite permanent structural tract disconnection, highlighting key implications for stroke rehabilitation.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today